Tumor Immunotherapy
mTOR Signaling and Cancer Progression
Interactions Between Signaling Pathways
Tumor Progression
Cancer-Critical Genes II: Tumor Suppressor Genes
The Tumor Microenvironment
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Joseph L Benci1, Bihui Xu1, Yu Qiu1
1Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
长时间的干扰素信号驱动抗癌免疫疗法,如PD1阻断. 抑制这种信号可以恢复抗瘤免疫力,并改善对检查点抑制剂的反应.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: